Delivery Order SPE2DB22D3301-SPE2DB25FX9VK
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $17,404.42 and an ultimate completion date of August 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the pharmaceutical products to the government under this contract. This award is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,152.18, is for the supply of Ondansetron ODT 8 mg tablets to support military healthcare programs. The contract type is Firm Fixed Price, and the ultimate completion date is February 7, 2025. This order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.54 contract is for the delivery of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC allows the DLA to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 doses of the medication Ondansetron ODT 8 mg Tablet, with a ceiling value of $1,400.16 and a period of performance through January 27, 2025. The contract is a firm fixed-price, delivery order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 8 mg tablets, valued at $3,226.60. The contract is a Firm Fixed Price Delivery Order with a period of performance extending through May 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $2,663.71 and is set to expire on August 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price for the provision of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $3,656.30 and runs through May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $43,312.56 and runs through May 17, 2024. It is a firm fixed-price contract with no set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron ODT 4 mg tablets for a total ceiling value of $5,488.01. The order has a firm fixed price and an ultimate completion date of August 27, 2024. AmerisourceBergen has a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for providing a...